Medical Policy Preimplantation Genetic Testing
|
|
- Susanna Morton
- 1 years ago
- Views:
Transcription
1 Medical Policy Preimplantation Genetic Testing Table of Contents Policy: Commercial Coding Information Information Pertaining to All Policies Policy: Medicare Description References Authorization Information Policy History Endnotes Policy Number: 088 BCBSA Reference Number: Related Policies Reproductive Techniques, #475 Policy Commercial Members: Managed Care (HMO and POS), PPO, and Indemnity Medicare HMO Blue SM and Medicare PPO Blue SM Members Preimplantation genetic diagnosis (PGD) may be MEDICALLY NECESSARY as an adjunct to in vitro fertilization (IVF) in couples not known to be infertile who meet one of the following criteria subject to careful consideration of the technical and ethical issues involved: For evaluation of an embryo at an identified elevated risk of a genetic disorder, such as when: o Both partners are known carriers of a single gene autosomal recessive disorder, o One partner is a known carrier of a single gene autosomal recessive disorder and the partners have one offspring that has been diagnosed with that recessive disorder, o One partner is a known carrier of a single gene autosomal dominant disorder, or o One partner is a known carrier of a single X-linked disorder. For evaluation of an embryo at an identified elevated risk of structural chromosomal abnormality, such as for a: o Parent with balanced or unbalanced chromosomal translocation. Preimplantation genetic diagnosis (PGD) as an adjunct to IVF is INVESTIGATIONAL in patients/couples who are undergoing IVF in all situations other than those specified above. Preimplantation genetic screening (PGS) as an adjunct to IVF is INVESTIGATIONAL in patients/couples who are undergoing IVF in all situations. Preimplantation genetic testing for all other indications, including a parent with a documented history of aneuploidy in a previous pregnancy, is INVESTIGATIONAL. 1 Prior Authorization Information Commercial Members: Managed Care (HMO and POS) 1
2 Commercial Members: PPO, and Indemnity Medicare Members: HMO Blue SM Medicare Members: PPO Blue SM CPT Codes / HCPCS Codes / ICD-9 Codes The following codes are included below for informational purposes. Inclusion or exclusion of a code does not constitute or imply member coverage or provider reimbursement. Please refer to the member s contract benefits in effect at the time of service to determine coverage or non-coverage as it applies to an individual member. Providers should report all services using the most up-to-date industry-standard procedure, revenue, and diagnosis codes, including modifiers where applicable. CPT Codes CPT codes: Code Description Biopsy, oocyte polar body or embryo blastomere, microtechnique (for pre-implantation genetic diagnosis); less than or equal to 5 embryos Biopsy, oocyte polar body or embryo blastomere, microtechnique (for pre-implantation genetic diagnosis); greater than 5 embryos Description Preimplantation genetic testing (PGT) involves analysis of biopsied cells as part of an assisted reproductive procedure. It is generally considered to be divided into two categories: Preimplantation genetic diagnosis (PGD) is used to detect a specific inherited disorder and aims to prevent the birth of affected children in couples at high risk of transmitting a disorder. Preimplantation genetic screening (PGS) uses similar techniques to screen for potential genetic abnormalities in conjunction with in vitro fertilization for couples without a specific known inherited disorder. Preimplantation genetic testing (PGT) describes a variety of adjuncts to an assisted reproductive procedure in which either maternal or embryonic DNA is sampled and genetically analyzed, thus permitting deselection of embryos harboring a genetic defect prior to implantation of the embryo into the uterus. The ability to identify preimplantation embryos with genetic defects before the initiation of pregnancy provides an attractive alternative to amniocentesis or chorionic villus sampling (CVS), with selective pregnancy termination of affected fetuses. Two different sources of genetic material may be sampled in PGT; either the first or second polar body of the oocyte may be sampled which focuses on maternal chromosomal abnormalities or the preimplantation embryo may be biopsied to detect genetic abnormalities arising from the maternal or paternal genetic material. The biopsied material can be analyzed in a variety of ways. Polymerase chain reaction (PCR) or other amplification techniques can be used to amplify the harvested DNA with subsequent analysis for single genetic defects. This technique is most commonly used when the embryo is at risk for a specific genetic disordersuch as Tay Sachs disease or cystic fibrosis. Fluorescent in situ hybridization (FISH) is a technique that allows direct visualization of specific (but not all) chromosomes to determine the number or absence of chromosomes. This technique is most commonly used to screen for aneuploidy, gender determination or to identify chromosomal translocations. FISH cannot be used to diagnose single genetic defect disorders. However, molecular techniques can be applied with FISH (such as microdeletions and duplications) and thus, single-gene defects can be recognized with this technique. 2
3 Another approach that is becoming more common is array comparative genome hybridization (CGH) testing at either the 8-cell or more often, the blastocyst stage. Unlike FISH analysis, this allows for 24 chromosome aneuploidy screening, as well as more detailed screening for unbalanced translocations and inversions and other types of abnormal gains and losses of chromosomal material. Three general categories of embryos have undergone PGT: 1. Embryos at risk for a specific inherited single genetic defect Inherited single-gene defects fall into 3 general categories: autosomal recessive, autosomal dominant, and X-linked. When either the mother or father is a known carrier of a genetic defect, embryos can undergo PGD to deselect embryos harboring the defective gene. Gender selection of a female embryo is another strategy when the mother is a known carrier of an X-linked disorder for which there is not yet a specific molecular diagnosis. The most common example is female carriers of fragile X syndrome. In this scenario, PGD is used to deselect male embryos, half of which would be affected. PGD could also be used to deselect affected male embryos. While there is a growing list of single genetic defects for which molecular diagnosis is possible, the most common indications include cystic fibrosis, beta thalassemia, muscular dystrophy, Huntington's disease, hemophilia, and fragile X disease. It should be noted that when PGD is used to deselect affected embryos, the treated couple is not technically infertile but are undergoing an assisted reproductive procedure for the sole purpose of PGD. In this setting, PGD may be considered an alternative to selective termination of an established pregnancy after diagnosis by amniocentesis or chorionic villus sampling. 2. Embryos at a higher risk of translocations Balanced translocations occur in 0.2% of the neonatal population but at a higher rate in infertile couples or in those with recurrent spontaneous abortions. PGD can be used to deselect those embryos carrying the translocations, thus leading to an increase in fecundity or a decrease in the rate of spontaneous abortion. 3. Identification of aneuploid embryos Implantation failure of fertilized embryos is a common cause for failure of assisted reproductive procedures; aneuploidy of embryos is thought to contribute to implantation failure and may also be the cause of recurrent spontaneous abortion. The prevalence of aneuploid oocytes increases in older women. These age-related aneuploidies are mainly due to nondisjunction of chromosomes during maternal meiosis. Therefore, PGS of the extruded polar bodies from the oocyte has been explored as a technique to deselect aneuploid oocytes in older women. The FISH technique is most commonly used to detect aneuploidy. Summary Preimplantation genetic testing has been shown to be technically feasible in detecting single gene defects, structural chromosomal abnormalities, and aneuploid embryos using a variety of biopsy and molecular diagnostic techniques. Ultimately, the choice is one of the risks (both medical and psychological) of undergoing IVF with PGD, compared to the option of normal fertilization and pregnancy with the possibility of a subsequent elective abortion. PGD is considered medically necessary, as noted in the policy statements, when the evaluation is focused on a known disease or disorder, and the decision to undergo PGD is made upon careful consideration of the risks and benefits. There is insufficient evidence that preimplantation genetic screening improves ongoing pregnancy and live birth rates; thus, preimplantation genetic screening as an adjunct to in vitro fertilization is considered investigational. Policy History Date Action 9/2014 New references added from BCBSA National medical policy. 1/2014 BCBSA National medical policy review. Medically necessary statement clarified. Effective 1/1/
4 9/2013 New investigational indications described. Effective 9/1/ /2013 BCBSA National medical policy review. No change in medical policy statement. Effective 2/4/ /2011- Medical policy ICD 10 remediation: Formatting, editing and coding updates. 4/2012 9/2011 Reviewed - Medical Policy Group - Urology and Obstetrics/Gynecology. 12/15/2010 Updated to add infertility treatment for a member with recurrent pregnancy loss in accordance with Massachusetts law (M.G.L.c. 175, section 47H and 211 C.M.R 37.09). Effective December 15, /1/2009 BCBSA National medical policy review. Changes to policy statements. 10/2009 Reviewed - Medical Policy Group - Urology and Obstetrics/Gynecology. 10/2009 Revised to include benefit coverage information in the header section of the document that addresses infertility services when a healthy female member is age 35 or older and has not been able to conceive after a period of six months of actively trying. 3/2009 BCBSA National medical policy review. 1/2009 Updated to remove information regarding requirement of 3 FSH IUI prior to receiving IVF treatment for those that meet the definition of unexplained infertility; this change is effective January 2009 as published in the December 08 Provider Focus. 11/2008 BCBSA National medical policy review. Changes to policy statements. 10/2008. Reviewed - Medical Policy Group - Urology and Obstetrics/Gynecology. 2/2008 Policy edited with the removal of coverage references for preimplantation genetic diagnosis which is now addressed in a new medical policy document, #88. 10/2007 Reviewed - Medical Policy Group - Urology and Obstetrics/Gynecology. Information Pertaining to All Blue Cross Blue Shield Medical Policies Click on any of the following terms to access the relevant information: Medical Policy Terms of Use Managed Care Guidelines Indemnity/PPO Guidelines Clinical Exception Process Medical Technology Assessment Guidelines References 1. Treff NR, Fedick A, Tao X et al. Evaluation of targeted next-generation sequencing-based preimplantation genetic diagnosis of monogenic disease. Fertil Steril 2013; 99(5): e6. 2. Martin J, Cervero A, Mir P et al. The impact of next-generation sequencing technology on preimplantation genetic diagnosis and screening. Fertil Steril 2013; 99(4): e3. 3. Chang LJ, Chen SU, Tsai YY et al. An update of preimplantation genetic diagnosis in gene diseases, chromosomal translocation, and aneuploidy screening. Clin Exp Reprod Med 2011; 38(3): Harper JC, Sengupta SB. Preimplantation genetic diagnosis: state of the art Hum Genet 2012; 131(2): Harper JC, Coonen E, De Rycke M et al. ESHRE PGD Consortium data collection X: cycles from January to December 2007 with pregnancy follow-up to October Hum Reprod 2010; 25(11):
5 6. Centers for Disease Control. Assisted Reproductive Technology: Success Rates: National Summary and Fertility Clinic Reports Available online at: Last accessed May, Strom CM, Strom S, Levine E et al. Obstetric outcomes in 102 pregnancies after preimplantation genetic diagnosis. Am J Obstet Gynecol 2000; 182(6): Franssen MT, Musters AM, van der Veen F et al. Reproductive outcome after PGD in couples with recurrent miscarriage carrying a structural chromosome abnormality: a systematic review. Hum Reprod Update 2011; 17(4): Keymolen K, Staessen C, Verpoest W et al. Preimplantation genetic diagnosis in female and male carriers of reciprocal translocations: clinical outcome until delivery of 312 cycles. Eur J Hum Genet 2012; 20(4): Scriven PN, Flinter FA, Khalaf Y et al. Benefits and drawbacks of preimplantation genetic diagnosis (PGD) for reciprocal translocations: lessons from a prospective cohort study. Eur J Hum Genet Checa MA, Alonso-Coello P, Sola I et al. IVF/ICSI with or without preimplantation genetic screening for aneuploidy in couples without genetic disorders: a systematic review and meta-analysis. J Assist Reprod Genet 2009; 26(5): Mastenbroek S, Twisk M, van der Veen F et al. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update 2011; 17(4): Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review. Reprod Biol Endocrinol 2014; 12: Mastenbroek S, Twisk M, van Echten-Arends J et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med 2007; 357(1): Beukers F, van der Heide M, Middelburg KJ et al. Morphologic abnormalities in 2-year-old children born after in vitro fertilization/intracytoplasmic sperm injection with preimplantation genetic screening: follow-up of a randomized controlled trial. Fertil Steril 2013; 99(2): Schendelaar P, Middelburg KJ, Bos AF et al. The effect of preimplantation genetic screening on neurological, cognitive and behavioural development in 4-year-old children: follow-up of a RCT. Hum Reprod 2013; 28(6): Rubio C, Bellver J, Rodrigo L et al. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertil Steril 2013; 99(5): Debrock S, Melotte C, Spiessens C et al. Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertil Steril 2010; 93(2): Ethics Committee of the American Society for Reproductive M. Use of preimplantation genetic diagnosis for serious adult onset conditions: a committee opinion. Fertil Steril 2013; 100(1): ACOG Committee Opinion No. 430: preimplantation genetic screening for aneuploidy. Obstet Gynecol 2009; 113(3): Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril 2007; 88(6): Endnotes 1 Based on ASRM guidelines 5
Preimplantation Genetic Testing in Embryos
MEDICAL POLICY POLICY RELATED POLICIES POLICY GUIDELINES DESCRIPTION SCOPE BENEFIT APPLICATION RATIONALE REFERENCES CODING APPENDIX HISTORY Preimplantation Genetic Testing in Embryos Number 12.04.305 Effective
Medical Policy Manual. Topic: Preimplantation Genetic Testing Date of Origin: August 2010. Section: Genetic Testing Last Reviewed Date: May 2016
Medical Policy Manual Topic: Preimplantation Genetic Testing Date of Origin: August 2010 Section: Genetic Testing Last Reviewed Date: May 2016 Policy No: 18 Effective Date: June 1, 2016 IMPORTANT REMINDER
The following chapter is called "Preimplantation Genetic Diagnosis (PGD)".
Slide 1 Welcome to chapter 9. The following chapter is called "Preimplantation Genetic Diagnosis (PGD)". The author is Dr. Maria Lalioti. Slide 2 The learning objectives of this chapter are: To learn the
Empowering accurate genetic answers for IVF clinics. Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) solutions.
Empowering accurate genetic answers for IVF clinics. Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) solutions. Uncovering answers for informed choices. Illumina is
Preimplantation Genetic Diagnosis (PGD) in Western Australia
Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome
PGD: Preimplantation Genetic Diagnosis
Testing on Embryo PGD, PND Mohammad Keramatipour MD, PhD Keramatipour@tums.ac.ir Testing on Embryos Pre-implantation Genetic Diagnosis (PGD) Early embryo Pre-natal Diagnosis (PND) First trimester Second
Preimplantation Genetic Diagnosis. Evaluation for single gene disorders
Preimplantation Genetic Diagnosis Evaluation for single gene disorders What is Preimplantation Genetic Diagnosis? Preimplantation genetic diagnosis or PGD is a technology that allows genetic testing of
Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2
August 2012 content 8 Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2 Maintaining fertility new opportunities in GENNET...3 Hysteroscopy without
Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics. January 2006
Minimum standards for ICSI use, screening, patient information and follow-up in WA fertility clinics January 2006 1. BACKGROUND ICSI has been shown to be effective for male factor infertility and it also
Present and future role of PGS according to different clinical indications Anna Pia Ferraretti, Cristina Magli, Luca Gianaroli SISMER- Bologna - Italy
PCC 1: Clinical aspects of PGD/PGS Present and future role of PGS according to different clinical indications Anna Pia Ferraretti, Cristina Magli, Luca Gianaroli SISMER- Bologna - Italy Classical indications
Preimplantation Genetic Diagnosis (PGD) Guiding Principles for Commissioners of NHS services
1 Preimplantation Genetic Diagnosis (PGD) Guiding Principles for Commissioners of NHS services 1. Summary Preimplantation genetic diagnosis (PGD) is an extension of prenatal diagnosis, using IVF technology
Innovators in Reproductive Genetics
ANEUPLOIDY DIAGNOSTICS DIAGNOSTICS EXCELLENCE 6182 DIAGNOSTICS PERFORMED OVER 10 YEARS OF EXPERIENCE PGS-NGS 360 PGD DIAGNOSIS SINCE 2005 TRANSLOCATION DIAGNOSIS NEXT GENERATION SEQUENCING Innovators in
LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES. Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD
LEUKODYSTROPHY GENETICS AND REPRODUCTIVE OPTIONS FOR AFFECTED FAMILIES Leila Jamal, ScM Kennedy Krieger Institute, Baltimore MD 2 Outline Genetics 101: Basic Concepts and Myth Busting Inheritance Patterns
Preimplantation Diagnosis for Monogenic Disorders
Preimplantation Diagnosis for Monogenic Disorders Many serious genetic diseases are caused by an error, or mutation, in a precise location in a particular gene. Preimplantation Genetic Diagnosis (PGD)
A Patient Counseling Guide for Reproductive Genetics. Educational content provided by
A Patient Counseling Guide for Reproductive Educational content provided by Table of contents 3 12 37 44 51 54 57 This Counseling Guide is intended to offer health care providers basic information on genetic
Ehlers-Danlos Syndrome Fertility Issues. Objectives
Ehlers-Danlos Syndrome Fertility Issues Baltimore Inner Harbor Independence Day Brad Hurst, M.D. Professor Reproductive Endocrinology Carolinas Medical Center - Charlotte, North Carolina Objectives Determine
How to evaluate success with PGS
How to evaluate success with PGS Don Leigh ASPIRE April 2014 IVF... What can be done to improve things? ~2/3 of clinical miscarriages are caused by chromosome aneuploidy Some aneuploidies are not observed
Array comparative genomic hybridization: its role in preimplantation genetic diagnosis
REVIEW C URRENT OPINION Array comparative genomic hybridization: its role in preimplantation genetic diagnosis Francesco Fiorentino Purpose of review Embryo assessment is a crucial component to the success
Patient information Pre-implantation genetic screening (PGS)
Page 1 of 5 Patient information Pre-implantation genetic screening (PGS) SUMMARY Pre-implantation genetic screening (PGS) analyses the genetic constitution of an egg or embryo to determine whether the
Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)
Consent to Perform Preimplantation Genetic Screening (PGS) using Array Comparative Genomic Hybridization (acgh ) or Next Generation Sequencing (NGS) Purpose The purpose of Preimplantation Genetic Screening
Will your child be sick as well? Testing before pregnancy. B. Gulbis, M.D., PhD
Will your child be sick as well? Testing before pregnancy B. Gulbis, M.D., PhD Université Libre de Bruxelles Brussels, Belgium 6 th EUROPEAN SYMPOSIUM ON RARE ANAEMIAS 1 st Dutch-Belgian meeting for patients
Empower your lab. Preimplantation genetic screening solutions.
Empower your lab. Preimplantation genetic screening solutions. Leading preimplantation genetic screening (PGS) solutions. Improve IVF success rates by optimizing embryo selection. Illumina offers a full
Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota
Carol Ludowese, MS, CGC Certified Genetic Counselor HDSA Center of Excellence at Hennepin County Medical Center Minneapolis, Minnesota The information provided by speakers in workshops, forums, sharing/networking
Outcome and future of children born after ART. M. Aboulghar Professor, Cairo University Clinical Director, The Egyptian IVF center
Outcome and future of children born after ART M. Aboulghar Professor, Cairo University Clinical Director, The Egyptian IVF center Possible effects on the babies could be from 1. Prematurity and multiple
The genetic screening of preimplantation embryos by comparative genomic hybridisation
Vol. 11, Suppl. 3 51 The genetic screening of preimplantation embryos by comparative genomic hybridisation Maria V Traversa 1, James Marshall, Steven McArthur, Don Leigh Genea, Sydney, Australia Received:
Preimplantation Genetic Diagnosis (PGD) for Fanconi Anemia and HLA matching
Preimplantation Genetic Diagnosis (PGD) for Fanconi Anemia and HLA matching Andria G. Besser, BEd, MS, CGC Licensed Genetic Counselor Reproductive Genetics Institute Chicago, IL Outline PGD overview In
SELECTCCS. Your guide to aneuploidy screening
SELECTCCS Your guide to aneuploidy screening GROWING FAMILIES What is SelectCCS? Available only through the Foundation for Embryonic Competence (FEC), SelectCCS is the most well-validated and proven method
Preimplantation Genetic Screening (PGS) Aneuploidy. A patient guide
Preimplantation Genetic Screening (PGS) Aneuploidy A patient guide Reproductive Genetic Innovations, LLC 2910 MacArthur Boulevard Northbrook, Illinois 60062 Phone: (847) 400-1515 Fax: (847) 400-1516 Email:
Genetic Screening and Testing During Pregnancy
Genetic Screening and Testing During Pregnancy While most babies are born healthy and without birth defects, approximately 3-5% of all babies are born with a birth defect. Some of these babies will have
MEDICAL POLICY SUBJECT: PRENATAL GENETIC TESTING. POLICY NUMBER: 4.01.03 CATEGORY: Laboratory Test
MEDICAL POLICY SUBJECT: PRENATAL GENETIC TESTING PAGE: 1 OF: 8 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
Topic: Novel Genetic Testing in ART. Matchuporn Sukprasert
Topic: Novel Genetic Testing in ART Matchuporn Sukprasert Topic: Novel Genetic Testing in ART Next-generation sequencing (NGS) The frequency of aneuploidy status of Day 5 and Day 6 blastocysts assessed
PGD: Genetic Testing of Embryos in the United States
PGD: Genetic Testing of Embryos in the United States Susannah Baruch, JD Genetics and Public Policy Center Johns Hopkins University February 15, 2009 Preimplantation Genetic Diagnosis Genetic testing of
Fertility Associates of Memphis, Memphis, TN. Corresponding author email: pbrezina@fertilitymemphis.com
Clinical Medicine Insights: Reproductive Health Perspective Open Access Full open access to this and thousands of other papers at http://www.la-press.com. Preimplantation Genetic Screening: A Practical
CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA
CHROMOSOMES Dr. Fern Tsien, Dept. of Genetics, LSUHSC, NO, LA Cytogenetics is the study of chromosomes and their structure, inheritance, and abnormalities. Chromosome abnormalities occur in approximately:
GENETIC COUNSELING, FAMILY PLANNING, IVF AND PGD. Jacinda Sampson MD PhD August 18, 2012
GENETIC COUNSELING, FAMILY PLANNING, IVF AND PGD Jacinda Sampson MD PhD August 18, 2012 Genetic Counseling What is genetic counseling? Dialogue between you and counselor Counselor can be: Physician with
Basic Human Genetics: Reproductive Health and Chromosome Abnormalities
Basic Human Genetics: Reproductive Health and Chromosome Abnormalities Professor Hanan Hamamy Department of Genetic Medicine and Development Geneva University Switzerland Training Course in Sexual and
In - Vitro Fertilization Handbook
In - Vitro Fertilization Handbook William F. Ziegler, D.O. Medical Director Scott Kratka, ELD, TS Embryology Laboratory Director Lauren F. Lucas, P.A.-C, M.S. Physician Assistant Frances Cerniak, R.N.
Enrolling a Patient for Preimplantation Genetic Diagnosis
Enrolling a Patient for Preimplantation Genetic Diagnosis IVF-Reproductive Center Patient Referral Register the Couple: Simply complete our patients information form for the couple. This acts as a physician
Preimplantation Genetic Diagnosis (PGD) Aneuploidy. A patient guide
Preimplantation Genetic Diagnosis (PGD) Aneuploidy A patient guide Reproductive Genetics Institute 2825 N. Halsted Street Chicago, IL 60657 Phone: 773-472-4900 Fax: 773-871-5221 Email: info@reproductivegenetics.com
REI Pearls: Pitfalls of Genetic Testing in Miscarriage
The Skinny: Genetic testing of miscarriage tissue is controversial and some people question if testing is helpful or not. This summary will: 1) outline the arguments for and against genetic testing; 2)
Preimplantation genetic diagnosis in Saudi Arabia
www.bioinformation.net Hypothesis Volume 9(8) Preimplantation genetic diagnosis in Saudi Arabia Zeinab Abotalib Department of Obstetrics and Gynecology, King Khalid University Hospital, College of Medicine,
Chapter 2. Scientific basis
7 Chapter 2 Scientific basis What genes are 2.1 The inheritance of all our characteristics, including susceptibility to genetic diseases, is dependent on genes and chromosomes. Genes are large molecules
Ch. 15: Chromosomal Abnormalities
Ch 15: Chromosomal Abnormalities Abnormalities in Chromosomal Number Abnormalities in Chromosomal Structure: Rearrangements Fragile Sites Define: nondisjunction polyploidy aneupoidy trisomy monosomy Abnormalities
GENETICS QUESTIONNAIRE & CONSENT FORM
Name (F) Name (M) GENETICS QUESTIONNAIRE & CONSENT FORM DOB: DOB: ***Please answer the following questions about yourself, your partner and your related family members with as much detail as possible.
Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups
Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups File name: Infertility Services File code: UM.REPRO.01 Last Review: 02/2016
Assisted Reproductive Techniques
Rule Category: Medical ` Ref: No: 2013-MN-0001 Version Control: Version No. 2.1 Effective Date: May 2013 Revision Date: May 2016 Assisted Reproductive Techniques Adjudication Rule Table of content Abstract
Genetics and Pregnancy Loss
Genetics and Pregnancy Loss Dorothy Warburton Genetics and Development (in Pediatrics) Columbia University, New York Estimates of Pregnancy Loss from Conception 1000 fertilized eggs (27% are lost) 728
HUMAN FERTILISATION AND EMBRYOLOGY AUTHORITY AND ADVISORY COMMITTEE ON GENETIC TESTING CONSULTATION DOCUMENT ON PREIMPLANTATION GENETIC DIAGNOSIS
HUMAN FERTILISATION AND EMBRYOLOGY AUTHORITY AND ADVISORY COMMITTEE ON GENETIC TESTING CONSULTATION DOCUMENT ON PREIMPLANTATION GENETIC DIAGNOSIS Introduction 1. This document considers the current and
FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?
FERTILITY AND AGE Introduction Delaying pregnancy is a common choice for women in today's society. The number of women in their late 30s and 40s attempting pregnancy and having babies has increased in
Ethics of Genetic Testing and Research in the Arab Region in Relation to Religious and Cultural Values Maryam A.G.Dashti, Ph.D
Ethics of Genetic Testing and Research in the Arab Region in Relation to Religious and Cultural Values Maryam A.G.Dashti, Ph.D Al Jawhara Hospital for Fertility and Genetic Diagnosis Department of Molecular
24sure TM Setting new standards in IVF
24sure TM Setting new standards in IVF 24sure TM The clinical challenge While in vitro fertilization (IVF) is a highly successful medical intervention that has revolutionized the treatment of infertility,
Preimplantation genetic screening (PGS)
Preimplantation genetic screening (PGS) Dagan Wells Reprogenetics UK In vitro fertilization (IVF) A highly successful medical intervention Infertility treatment revolutionized Estimated that >5 million
Clinical applications of preimplantation genetic testing
Clinical applications of preimplantation genetic testing Paul R Brezina, 1 2 William H Kutteh 1 2 1 Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Vanderbilt
Corporate Medical Policy Noninvasive Prenatal Testing for Fetal Aneuploidies Using Cell- Free Fetal DNA
Corporate Medical Policy Noninvasive Prenatal Testing for Fetal Aneuploidies Using Cell- File Name: Origination: Last CAP Review: Next CAP Review: Last Review: noninvasive_prenatal_testing_for_fetal_aneuploidies_using_cell-free_fetal_dna
Produced by the Centre for Genetics Education. Internet: 7
Important points In each human cell, except the egg and sperm cells, there are 46 paired chromosomes of varying size One chromosome of each pair is inherited from each parent The autosomes are chromosomes
Genetic methods for assessing embryo viability and improving IVF treatment
Genetic methods for assessing embryo viability and improving IVF treatment Prof. Dagan Wells, PhD, FRCPath Reprogenetics UK Points for discussion Diagnosis of inherited disorders in preimplantation embryos
Setting new standards in IVF
Setting new standards in IVF The clinical challenge Embryo aneuploidy is known to increase with maternal age, causing increase in miscarriage rates and decrease in live birth rates. Due to this age related
PATIENT EDUCATION. carrier screening INFORMATION
PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your
Abnormalities of Chromosome Structure
Abnormalities of Chromosome Structure Structural rearrangements result from chromosome breakage, followed by reconstitution in an abnormal combination. Whereas rearrangements can take place in many ways,
information for patients Chromosome Translocations
information for patients Chromosome Translocations CCLINICAL GENETICS LINICAL GENETICS Introduction You may have been told that you, or a member of your family, have what is known as a chromosome translocation.
Pre-implantation genetic screening and diagnosis: what doctors should know
Sammya Bezerra Maia e Holanda Moura 1,3 Stefan Charles Kane 1,2 Fabricio da Silva Costa 1,2,4 Pre-implantation genetic screening and diagnosis: what doctors should know Rastreio ou diagnóstico genético
Fertility Research Policy
Fertility Research Policy Rationale and Objective Merck Serono has a strong commitment to deliver innovations in Fertility treatments to help infertile couples achieve their desire to have a baby. Innovations
Genetic Disorders. Things Can Go Wrong With DNA and Chromosomes
Genetic Disorders Things Can Go Wrong With DNA and Chromosomes I. Overview of DNA Structure A. Review 1. A gene is a segment of DNA that codes for a particular protein 2. Proteins determine the physical
Chromosomes, Karyotyping, and Abnormalities (Learning Objectives) Learn the components and parts of a metaphase chromosome.
Chromosomes, Karyotyping, and Abnormalities (Learning Objectives) Learn the components and parts of a metaphase chromosome. Define the terms karyotype, autosomal and sex chromosomes. Explain how many of
Research article. Paul N. Scriven 1,2, *
http://www.aimspress.com/journal/genetics AIMS Genetics, 3(3): 177-195. DOI: 10.3934/genet.2016.3.177 Received: 27 June 2016 Accepted: 23 September 2016 Published: 28 September 2016 Research article Towards
Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao.
Welcome to chapter 2. The following chapter is called "Indications For IVF". The author is Dr Kamini A. Rao. The indications for an IVF treatment have increased since the birth of the first IVF baby. The
Article Wide range of chromosome abnormalities in the embryos of young egg donors
RBMOnline - Vol 12. No 3. 2006 340-346 Reproductive BioMedicine Online; www.rbmonline.com/article/2050 on web 12 January 2006 Article Wide range of chromosome abnormalities in the embryos of young egg
Preimplantation genetic testing: a Practice Committee opinion
Preimplantation genetic testing: a Practice Committee opinion The Practice Committee of the Society for Assisted Reproductive Technology and the Practice Committee of the American Society for Reproductive
This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive.
11111 This fact sheet describes how genes affect our health when they follow a well understood pattern of genetic inheritance known as autosomal recessive. In summary Genes contain the instructions for
Reproductive Technology. Chapter 21
Reproductive Technology Chapter 21 Assisted Reproduction When a couple is sub-fertile or infertile they may need Assisted Reproduction to become pregnant: Replace source of gametes Sperm, oocyte or zygote
The more varied population is older because the mtdna has had more time to accumulate mutations.
Practice problems (with answers) This is the degree of difficulty of the questions that will be on the test. This is not a practice test because I did not consider how long it would take to finish these
Assisted Reproductive Technologies at IGO
9339 Genesee Avenue, Suite 220 San Diego, CA 92121 858 455 7520 Assisted Reproductive Technologies at IGO Although IGO no longer operates an IVF laboratory or program as such, we work closely with area
Single Gene Testing. Using Preimplantation Genetic Diagnosis
Single Gene Testing Using Preimplantation Genetic Diagnosis Single gene testing using preimplantation genetic diagnosis (PGD) is a highly sophisticated scientific technique, whereby embryos can be tested
What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives
What Is Genetic Counseling? Helping individuals and families understand how genetics affects their health and lives What does the career involve? Explore family histories to identify risks Reducing risks
Heredity and Environment
3 CHAPTER Heredity and Environment Chapter Preview Much is determined at the moment of conception, when a sperm and ovum unite to initiate the developmental processes that will culminate in the birth of
Obstetrical Ultrasound and Prenatal Diagnostic Center
Obstetrical Ultrasound and Prenatal Diagnostic Center Prenatal Diagnosis: Options and Opportunities Learn about various screening options including Early Risk Assessment (ERA), now available to women of
Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register
1 Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register Joanne Gunby, M.Sc. CARTR Co-ordinator Email: gunbyj@mcmaster.ca Supported by the IVF Directors Group of
AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com
Page 1 of 6 AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com Age has a profound effect on female fertility. This is common knowledge,
Pre-Implantation Genetic Diagnosis and Prion Diseases. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis and Prion Diseases Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Disclaimer: We are not Prion researchers. We are not Reproductive Endocrinologists/Geneticists. We do
Genetics. Genetics Disorders
Genetics Nsg 3027 Women s Health Introduction Genetic disorders occur approximately 1 in 20 or 30% of pediatric admissions National Health Care Goals: Increase prenatal screening to 90% of pregnancies.
Preimplantation Genetic Diagnosis (PGD) and Childhood Diagnostic Evaluation
IG O Preimplantation Genetic Diagnosis (PGD) and Childhood Diagnostic Evaluation KD Carsten Bergmann carsten.bergmann@bioscientia.de carsten.bergmann@uniklinik-freiburg.de Controversies Conference on ADPKD
IN VITRO FERTILIZATION (IVF) INFORMATION PACKAGE Form # CFRH -102 (13-Dec-2013)
Centre for Fertility & Reproductive Health 250 Dundas St W., Suite 700 Toronto, ON M5T 2Z5 tel: 416-586-4748; fax: 416-586-4686 IN VITRO FERTILIZATION (IVF) INFORMATION PACKAGE Form # CFRH -102 (13-Dec-2013)
Balanced. translocations. rarechromo.org. Support and Information
Support and Information Rare Chromosome Disorder Support Group, G1, The Stables, Station Rd West, Oxted, Surrey. RH8 9EE Tel: +44(0)1883 723356 info@rarechromo.org I www.rarechromo.org Balanced Unique
Chapter 24 Genetics and Genomics
Chapter 24 Genetics and Genomics Genetics study of inheritance of characteristics Genome complete set of genetic instructions Genomics field in which the body is studied in terms of multiple, interacting
What are genetic disorders?
What are genetic disorders? A disease caused by abnormalities in an individual s genetic material (genome) There are four types of genetic disorders 1. Single-gene (also called Mendelian or monogenic)
PGS-NGS 360 Preimplantation Genetic Screening
Genetic Laboratory PGS-NGS 360 Preimplantation Genetic Screening Innovators in Reproductive Genetics PGS-NGS 360 PGS-NGS 360 is a test for aneuploidy screening of all 24 chromosomes. Primplantation genetic
Controversy: Is IVF Associated with Increased Rate of Birth Defect
Controversy: Is IVF Associated with Increased Rate of Birth Defect R 5 謝佳琳 In Vitro Fertilization as Associated with an Increase in Major Birth Defects Christine K. Olson, M.D Division of Reproductive
Reproductive Endocrinology and Infertility
Reproductive Endocrinology and Infertility John A. Schnorr, M.D Michael J. Slowey, M.D. 1375 Hospital Drive Mount Pleasant, SC 29464 Phone: 843-883-5800 Fax: 843-606-3937 www.coastalfertilityspecialists.com
Testing for Chromosome Abnormalities
Testing for Chromosome Abnormalities Congratulations on your pregnancy! While most babies are born healthy, approximately 3-5% will be affected with certain birth defects or genetic conditions. In all
PRACTICE BULLETIN. Prenatal Diagnostic Testing for Genetic Disorders. Background
The American College of Obstetricians and Gynecologists WOMEN S HEALTH CARE PHYSICIANS (Published Electronically Ahead of Print on March 1, 2016) PRACTICE BULLETIN clinical management guidelines for obstetrician
Ethical issues in assisted reproductive technologies. Effy Vayena
Ethical issues in assisted reproductive technologies Effy Vayena Assisted Reproductive Technologies (ART) All treatments or procedures that include the in vitro handling of human oocytes and human sperm
Chromosome Analysis. Chromosome Analysis. Diagnostic Limits of Conventional Cytogenetic Analysis
Chromosome Analysis The best whole genome analysis technique currently available is.. GTG-banding of Metaphase chromosomes Chromosome Analysis G-banding provides a visual examination of the entire genome
MCB41: Second Midterm Spring 2009
MCB41: Second Midterm Spring 2009 Before you start, print your name and student identification number (S.I.D) at the top of each page. There are 7 pages including this page. You will have 50 minutes for
Section 1 Chromosomes and Inheritance. Section 2 Human Genetics. Resources
How to Use This Presentation To View the presentation as a slideshow with effects select View on the menu bar and click on Slide Show. To advance through the presentation, click the right-arrow key or
Executive summary. Current prenatal screening
Executive summary Health Council of the Netherlands. NIPT: dynamics and ethics of prenatal screening. The Hague: Health Council of the Netherlands, 2013; publication no. 2013/34. In recent years, new tests
GENETIC COUNSELING AND PRENATAL TESTING
GENETIC COUNSELING AND PRENATAL TESTING Every parent hopes to have a healthy child. The good news is most babies are born healthy. However, sometimes a genetic disease or birth defect may occur. If your
Technical Update: Preimplantation Genetic Diagnosis and Screening
No. 323, May 2015 (Replaces No. 232, August 2009) Technical Update: Preimplantation Genetic Diagnosis and Screening This technical update has been prepared by the Genetics Committee and approved by the
In Vitro Fertilization. New England Fertility
In Vitro Fertilization New England Fertility In Vitro Fertilization New England Fertility offers a wide variety of infertility treatments to individuals and couples struggling to conceive, including in
Lecture 32: Numerical Chromosomal Abnormalities and Nondisjunction. Meiosis I Meiosis II Centromere-linked markers
Lecture 32: Numerical Chromosomal Abnormalities and Nondisjunction Meiosis I Meiosis II Centromere-linked markers Female Male 46,XX 46,XY Human chromosomal abnormalities may be numerical or structural.
it right? activity (page 4) to highlight ethical issues associated with IVF
IN VITRO FERTILIZATION I V F In some cases, a sperm is directly injected into an egg IVF: THE MEETING OF SPERM AND EGG IN GLASS Louise Brown, the first test tube baby was born in 1978. Since then, there